Topotecan inhibits metastasis of non-small cell lung cancer by regulating epithelial-mesenchymal transition

• Hoofdauteurs: Zhen Liu (Auteur), Lvqian Guo (Auteur), Panpan Yin (Auteur), Feng Zhang (Auteur), Wenjuan Song (Auteur), Junling Gao (Auteur), Xinran Li (Auteur), Yuou Teng (Auteur), Peng Yu (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2022-08-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Lung cancer is a malignant disease with a high mortality rate and a poor prognosis, which is easy to metastasis and recurrence. Topotecan (TPT), an inhibitor of topoisomerase I (Topo I), is mainly used to treat metastatic small cell lung cancer, and it has shown effective treatment for non-small cel...